ZBH · NYSE · CIK 0001136869
ZIMMER BIOMET HOLDINGS, INC.
ZIMMER BIOMET HOLDINGS, INC.’s most recent SEC filing in our snapshot is a Form 4 filed on Oct 5, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $8.2B and net income of $705.1M, according to its XBRL data on EDGAR. Its EDGAR record lists 82 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- ZIMMER BIOMET HOLDINGS, INC.
- Ticker
- ZBH
- SEC Central Index Key (CIK)
- 0001136869
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (code 3842)
- Business address
- WARSAW, IN
- State or country of incorporation
- DE
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Position in SEC ticker list
- #614 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from ZIMMER BIOMET HOLDINGS, INC.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $6.8B | $6.9B | $7.4B | $7.7B | $8.2B |
| Net income | $401.6M | $231.4M | $1.0B | $903.8M | $705.1M |
| Diluted EPS | $1.91 | $1.10 | $4.88 | $4.43 | $3.55 |
| Total assets | $23.5B | $21.1B | $21.5B | $21.4B | $23.1B |
| Cash and equivalents | $378.1M | $375.7M | $415.8M | $525.5M | $591.9M |
XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
| Filed | Form | What it is | Original |
|---|---|---|---|
| Feb 20, 2026 | 10-K | Annual report· period Dec 31, 2025 | Document · Index |
| Aug 5, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Sep 8, 2026 | 8-K | Director or officer change; Regulation FD disclosure· period Sep 8, 2026 | Document · Index |
| Apr 1, 2026 | DEF 14A | Definitive proxy statement· period May 22, 2026 | Document · Index |
Recent SEC filings
The 40 newest documents filed by or about ZIMMER BIOMET HOLDINGS, INC., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026 | Document · Index |
| Oct 5, 2026 | 3 | Initial statement of beneficial ownership· period Oct 1, 2026 | Document · Index |
| Oct 5, 2026 | 3 | Initial statement of beneficial ownership· period Oct 1, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Oct 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 30, 2026 | Document · Index |
| Sep 15, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 11, 2026 | Document · Index |
| Sep 11, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Sep 9, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Sep 4, 2026 | Document · Index |
| Sep 8, 2026 | 8-K | Director or officer change; Regulation FD disclosure· period Sep 8, 2026 | Document · Index |
| Sep 4, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 13, 2026 | SCHEDULE 13G/A | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 12, 2026 | SCHEDULE 13G | Passive beneficial ownership report (over 5%) | Document · Index |
| Aug 5, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 3, 2026 | Document · Index |
| Aug 5, 2026 | 8-K | Other events· period Aug 5, 2026 | Document · Index |
| Aug 5, 2026 | 10-Q | Quarterly report· period Jun 30, 2026 | Document · Index |
| Aug 5, 2026 | 8-K | Results of operations· period Aug 5, 2026 | Document · Index |
| Aug 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 1, 2026 | Document · Index |
| Jul 23, 2026 | 3 | Initial statement of beneficial ownership· period Jul 13, 2026 | Document · Index |
| Jul 16, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jul 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jul 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jul 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jul 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jul 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jul 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jul 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jun 29, 2026 | 8-K | Material agreement; Agreement terminated; New financial obligation· period Jun 26, 2026 | Document · Index |
| Jun 24, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jun 3, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026 | Document · Index |
| Jun 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 29, 2026 | Document · Index |
| May 29, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| May 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 22, 2026 | Document · Index |
| May 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 22, 2026 | Document · Index |
| May 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 22, 2026 | Document · Index |
| May 27, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period May 22, 2026 | Document · Index |
Insider filing activity
82 Form 4 filings appear in ZIMMER BIOMET HOLDINGS, INC.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies
- ISRG INTUITIVE SURGICAL INC
- EW Edwards Lifesciences Corp
- STE STERIS plc
- SNN SMITH & NEPHEW PLC
- ALGN ALIGN TECHNOLOGY INC
- MSA MSA Safety Inc
- ESTA ESTABLISHMENT LABS HOLDINGS INC.
- CDRE Cadre Holdings, Inc.
All 11 companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies· Companies headquartered in Indiana
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001136869 and XBRL company facts. ZIMMER BIOMET HOLDINGS, INC. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement